{
    "pmcid": "8967028",
    "qa_pairs": {
        "What approach was used to enhance the binding affinity of VHH-72 to the SARS-CoV-2 spike protein?": [
            "A structure-based approach using the ADAPT platform for computational predictions and experimental validation.",
            "A chemical modification approach to alter the antibody's structure for better binding.",
            "A genetic engineering approach to insert additional binding domains into VHH-72.",
            "A viral vector approach to deliver VHH-72 directly to infected cells."
        ],
        "What is the primary target for therapeutic intervention to block viral entry of SARS-CoV-2 according to the paper?": [
            "The interaction between the SARS-CoV-2 spike protein and the human ACE2 receptor.",
            "The interaction between the SARS-CoV-2 nucleocapsid protein and host cell proteins.",
            "The interaction between the SARS-CoV-2 membrane protein and the host cell membrane.",
            "The interaction between the SARS-CoV-2 envelope protein and host cell receptors."
        ],
        "What is the significance of targeting a conserved epitope on the SARS-CoV-2 spike RBD?": [
            "It reduces the risk of mutational escape as the epitope is less prone to variations.",
            "It enhances the antibody's ability to bind to the ACE2 receptor.",
            "It increases the antibody's specificity for the SARS-CoV-2 spike protein.",
            "It allows the antibody to neutralize other unrelated viruses."
        ],
        "Which specific mutations were identified in the lead mutant of VHH-72 that improved its neutralization efficacy?": [
            "S56M, L97W, T99V",
            "A45G, F82Y, R100K",
            "D50N, Y102H, V105L",
            "G58R, Q95L, S101P"
        ],
        "Why is there a need for cross-reactive antibodies against SARS-CoV-2 variants?": [
            "To prevent viral escape due to mutations in the spike protein's receptor-binding domain.",
            "To enhance the immune response by targeting multiple viral proteins simultaneously.",
            "To increase the production of antibodies by stimulating different immune pathways.",
            "To improve the stability of antibodies in the presence of different viral strains."
        ]
    }
}